Next Article in Journal
Mental Health Challenges in Cancer Patients: A Cross-Sectional Analysis of Depression and Anxiety
Previous Article in Journal
Pre-Op Hydronephrosis Predicts Outcomes in Patients Receiving Robot-Assisted Radical Cystectomy
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Cancers
Volume 16
Issue 16
10.3390/cancers16162825
cancers-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Correction to Cancers 2020, 12(6), 1693.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Flammang et al. Tumor-Suppressive miR-192-5p Has Prognostic Value in Pancreatic Ductal Adenocarcinoma. Cancers 2020, 12, 1693

by
Isabelle Flammang
1,†,
Moritz Reese
1,†,
Anda J. Ströse
1,†,
Zixuan Yang
1,
Johannes A. Eble
2 and
Sameer A. Dhayat
1,*
1
Department of General, Visceral and Transplantation Surgery, University Hospital Muenster, Albert-Schweitzer-Campus 1 (W1), 48149 Muenster, Germany
2
Department of Physiological Chemistry and Pathobiochemistry, University of Muenster, Waldeyerstrasse 15, 48149 Muenster, Germany
*
Author to whom correspondence should be addressed.
†
These authors contributed equally to this work.
Cancers 2024, 16(16), 2825; https://doi.org/10.3390/cancers16162825
Submission received: 30 January 2024 / Accepted: 31 May 2024 / Published: 12 August 2024
(This article belongs to the Section Molecular Cancer Biology)
Versions Notes

1. Missing Funding

In the original publication [1], the research award of the Maria Moeller Foundation (no Grant Number) to Anda J. Ströse was not included.
The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

2. Addition of an Author

Anda J. Ströse was not included as an author in the original publication. The corrected Author Contributions Statement appears here.
Anda J. Ströse was involved in the conceptualization, project administration, investigation, and methodology, in the data curation, formal analysis, visualization, in the writing—original draft preparation of a first withdrawn manuscript, and in the funding acquisition by the Maria Moeller Stiftung, Muenster Germany.
The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Author Contributions

Conceptualization, S.A.D., I.F., M.R. and A.J.S.; methodology, M.R., S.A.D., I.F. and A.J.S.; validation, S.A.D., I.F., M.R.; formal analysis, M.R., I.F., Z.Y., S.A.D. and A.J.S.; investigation, I.F., M.R., S.A.D., Z.Y. J.A.E. and A.J.S.; resources, S.A.D.; data curation, I.F., S.A.D., M.R. and A.J.S.; writing—original draft preparation, I.F., S.A.D., M.R. and A.J.S.; writing—review and editing, I.F., M.R., S.A.D., Z.Y., J.A.E.; visualization, M.R., I.F. and A.J.S.; supervision, S.A.D.; project administration, S.A.D. and A.J.S.; funding acquisition, S.A.D. and A.J.S. All authors have read and agreed to the published version of the manuscript.

Funding

This research received external funding by the Maria Moeller Stiftung, Muenster, Germany (no Grant Number). Research on exosomal miRNAs as non-invasive biomarkers in PDAC was partly funded by a research grant of the Maria Moeller Stiftung, Muenster, Germany awarded to Anda J. Ströse. The material reflects only the authors’ point of view and funding partners are not liable for any use that may be made of the information contained therein.

Reference

  1. Flammang, I.; Reese, M.; Yang, Z.; Eble, J.A.; Dhayat, S.A. Tumor-Suppressive miR-192-5p Has Prognostic Value in Pancreatic Ductal Adenocarcinoma. Cancers 2020, 12, 1693. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Flammang, I.; Reese, M.; Ströse, A.J.; Yang, Z.; Eble, J.A.; Dhayat, S.A. Correction: Flammang et al. Tumor-Suppressive miR-192-5p Has Prognostic Value in Pancreatic Ductal Adenocarcinoma. Cancers 2020, 12, 1693. Cancers 2024, 16, 2825. https://doi.org/10.3390/cancers16162825

AMA Style

Flammang I, Reese M, Ströse AJ, Yang Z, Eble JA, Dhayat SA. Correction: Flammang et al. Tumor-Suppressive miR-192-5p Has Prognostic Value in Pancreatic Ductal Adenocarcinoma. Cancers 2020, 12, 1693. Cancers. 2024; 16(16):2825. https://doi.org/10.3390/cancers16162825

Chicago/Turabian Style

Flammang, Isabelle, Moritz Reese, Anda J. Ströse, Zixuan Yang, Johannes A. Eble, and Sameer A. Dhayat. 2024. "Correction: Flammang et al. Tumor-Suppressive miR-192-5p Has Prognostic Value in Pancreatic Ductal Adenocarcinoma. Cancers 2020, 12, 1693" Cancers 16, no. 16: 2825. https://doi.org/10.3390/cancers16162825

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop